MedTrace Logo

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

NCT02654340 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-02-10

No results posted yet for this study

Summary

International, multicenter, observational, longitudinal study to identify biomarker/s for Tuberous Sclerosis Complex and to explore the clinical robustness, specificity, and long´-term variability of these biomarker/s

Conditions

  • Hypomelanotic Macules
  • Facial Angiofibroma
  • Shagreen Patches
  • Ungual Fibromas
  • Cortical Dysplasia
  • Cardiac Rhabdomyoma
  • Lymphangioleiomyomatosis
  • Renal Angiomyolipoma
  • Subependymal Giant Cell Astrocytoma

Sponsors & Collaborators

  • CENTOGENE GmbH Rostock

    lead INDUSTRY

Principal Investigators

  • Peter Bauer, Prof.Dr · Centogene GmbH

Eligibility

Min Age
2 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • Albania
  • Egypt
  • Georgia
  • India
  • Lithuania
  • Pakistan
  • Romania
  • Sri Lanka

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02654340 on ClinicalTrials.gov